These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 16941367)

  • 1. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
    Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects.
    Vila-Córcoles A; Ochoa-Gondar O; Llor C; Hospital I; Rodríguez T; Gómez A
    Eur Respir J; 2005 Dec; 26(6):1086-91. PubMed ID: 16319340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
    Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
    Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia.
    Johnstone J; Eurich DT; Minhas JK; Marrie TJ; Majumdar SR
    Clin Infect Dis; 2010 Jul; 51(1):15-22. PubMed ID: 20504233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study.
    Ochoa-Gondar O; Vila-Corcoles A; Ansa X; Rodriguez-Blanco T; Salsench E; de Diego C; Raga X; Gomez F; Valdivieso E; Fuentes C; Palacios L;
    Vaccine; 2008 Apr; 26(16):1955-62. PubMed ID: 18343541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
    Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I
    Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study.
    Peñaranda M; Falco V; Payeras A; Jordano Q; Curran A; Pareja A; Samperiz G; Dalmau D; Ribera E; Riera M
    Clin Infect Dis; 2007 Oct; 45(7):e82-7. PubMed ID: 17806042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study.
    Hechter RC; Chao C; Jacobsen SJ; Slezak JM; Quinn VP; Van Den Eeden SK; Tseng HF
    Vaccine; 2012 Aug; 30(38):5625-30. PubMed ID: 22789510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia.
    Johnstone J; Marrie TJ; Eurich DT; Majumdar SR
    Arch Intern Med; 2007 Oct; 167(18):1938-43. PubMed ID: 17923592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.
    Andrews RM; Counahan ML; Hogg GG; McIntyre PB
    Vaccine; 2004 Nov; 23(2):132-8. PubMed ID: 15531029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.
    Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A;
    Hum Vaccin Immunother; 2012 May; 8(5):639-44. PubMed ID: 22634442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients.
    Gilbertson DT; Guo H; Arneson TJ; Collins AJ
    Nephrol Dial Transplant; 2011 Sep; 26(9):2934-9. PubMed ID: 21317410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia.
    Musher DM; Rueda-Jaimes AM; Graviss EA; Rodriguez-Barradas MC
    Clin Infect Dis; 2006 Oct; 43(8):1004-8. PubMed ID: 16983612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated.
    Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA
    Vaccine; 2007 Jun; 25(23):4631-40. PubMed ID: 17478015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease.
    Vila-Córcoles A; Ochoa O; de Diego C; Valdivieso A; Herreros I; Bobé F; Alvarez M; Juárez M; Guinea I; Ansa X; Saún N
    Int J Clin Pract; 2008 Jan; 62(1):10-7. PubMed ID: 17573840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
    Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
    Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.
    Kawakami K; Ohkusa Y; Kuroki R; Tanaka T; Koyama K; Harada Y; Iwanaga K; Yamaryo T; Oishi K
    Vaccine; 2010 Oct; 28(43):7063-9. PubMed ID: 20723631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia.
    Voordouw BC; Sturkenboom MC; Dieleman JP; Stijnen T; van der Lei J; Stricker BH
    Arch Intern Med; 2006 Oct; 166(18):1980-5. PubMed ID: 17030831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.